CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 155 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $12,830,350 | +140460.4% | 489,708 | +5.5% | 0.01% | +44.4% |
| Q3 2022 | $9,128 | +3.4% | 464,314 | -8.0% | 0.01% | 0.0% |
| Q2 2022 | $8,829 | -33.4% | 504,825 | -37.7% | 0.01% | 0.0% |
| Q1 2022 | $13,266 | -3.6% | 810,879 | -3.9% | 0.01% | +12.5% |
| Q4 2021 | $13,762 | +28.8% | 843,812 | +0.7% | 0.01% | +33.3% |
| Q3 2021 | $10,688 | -9.8% | 837,576 | -0.2% | 0.01% | 0.0% |
| Q2 2021 | $11,852 | -9.8% | 839,380 | -0.7% | 0.01% | -14.3% |
| Q1 2021 | $13,139 | -1.9% | 845,485 | +0.1% | 0.01% | 0.0% |
| Q4 2020 | $13,397 | +29.2% | 844,684 | -80.2% | 0.01% | 0.0% |
| Q3 2020 | $10,366 | – | 4,265,980 | – | 0.01% | – |
Download | ||||||